-
Dr. Peter Reiss: Moving Towards the Fourth “90” Goal – Strategies for Improving the Quality of Life and Management of HIV/AIDS Patients
-
Dr. Jennifer Hoy: How to Safely Transition ART in HIV Patients Achieving Viral Suppression?
-
Dr. Iskandar Azwa: Second and Third-Line Treatment Options for HIV/AIDS Patients
-
Dr. Heather-Marie Schmidt: WHO Long-Acting PrEP Guidelines and Priority Actions to End HIV Epidemic in Asia
-
Dr. Dong Hsu: Meeting More Patient Needs in HIV Health Management
-
Dr. Steven Grinspoon: Statin Drugs Can Be Used for Primary Prevention of Cardiovascular Diseases in HIV-Infected Individuals
-
Dr. Deborah Donnell: A new long-acting PrEP regimen holds promise to transform the landscape of HIV prevention.
-
Dr. Ana Hoxha: Clinical characteristics and outcomes of MPXV and HIV co-infected patients
-
Dr. Xinwei Wang: The Molecular Landscape and Clinical Significance of Liver Cancer
-
Dr. Huichuan Sun: Focusing on the Asia-Pacific Region, Leading the Frontier – Exploring Breakthroughs in the Treatment of Hepatobiliary Tumor
-
Dr. Gong Li: Combined Radiotherapy, Anti-Angiogenic Medication, and Immunotherapy for Downstaging Treatment in Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombus
-
Dr. Masatoshi Kudo: Does the Treatment Paradigm for Intermediate HCC Need to Change?
Connecting Medical Expertise through Media